Module 10 |
Section 1: Purchasing: Factors affecting price |
Pharmacology |
2023-01-17 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 4 |
Section 1 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
9 |
0 |
edit |
|
Module 4 |
Section 2 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 4 |
Section 3 Key terms and definitions |
Pharmacology |
2024-03-20 |
Lane.Wendy |
5 |
0 |
edit |
|
Module 4 |
Section 4 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
7 |
0 |
edit |
|
Module 4 |
Section 5 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
9 |
0 |
edit |
|
Module 4 |
Section 6 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
8 |
0 |
edit |
|
Module 4 |
Section 7 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 4 |
Section 8 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 4 |
Section 9 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
8 |
0 |
edit |
|
Module 4 |
Section 10 Key terms and definitions |
Pharmacology |
2023-08-29 |
Lane.Wendy |
9 |
0 |
edit |
|
Module 1 |
Section 1 Key terms and definitions |
Pharmacology |
2023-06-22 |
Lane.Wendy |
11 |
0 |
edit |
|
Module 1 |
Section 2 Key Terms and definitions |
Pharmacology |
2023-07-05 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 1 |
Section 3 Key Terms and definitions |
Pharmacology |
2023-01-09 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 1 |
Section 4 Key terms and definitions |
Pharmacology |
2023-01-09 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 1 |
Section 5 Key terms and definitions |
Pharmacology |
2023-01-09 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 2 |
Section 1 Dosage forms |
Pharmacology |
2023-07-05 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 2 |
Section 2 Prescription containers |
Pharmacology |
2023-07-05 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 2 |
Section 3 Generic products |
Pharmacology |
2023-07-05 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 2 |
Section 4 Stock bottle labels |
Pharmacology |
2023-07-06 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 2 |
Section 5 Easily confused products |
Pharmacology |
2023-07-06 |
Lane.Wendy |
8 |
0 |
edit |
|
Module 2 |
Section 6 Public safety and reporting errors |
Pharmacology |
2023-07-06 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 2 |
Section 7 Dispensing errors |
Pharmacology |
2023-07-06 |
Lane.Wendy |
9 |
0 |
edit |
|
Module 2 |
Section 8 Dispensing precautions during pregnancy |
Pharmacology |
2023-07-06 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 3 |
Section 1 Controlled substance schedules |
Pharmacology |
2023-07-31 |
Lane.Wendy |
7 |
0 |
edit |
|
Module 3 |
Section 2 Dispensing controlled substances |
Pharmacology |
2023-07-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 3 |
Section 3 DEA numbers, recordkeeping, and destruction of controlled substances |
Pharmacology |
2023-07-31 |
Lane.Wendy |
8 |
0 |
edit |
|
Module 3 |
Section 4 Diversion of controlled substances |
Pharmacology |
2023-07-31 |
Lane.Wendy |
4 |
0 |
edit |
|
Module 3 |
Section 5 Substance use disorder in patients and colleagues |
Pharmacology |
2023-07-31 |
Lane.Wendy |
7 |
0 |
edit |
|
Module 6 |
Section 1 Self-Management skills |
Pharmacology |
2023-01-09 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 6 |
Section 2 Key terms and definitions |
Pharmacology |
2023-01-09 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 6 |
Section 3: Teamwork, problem-solving, and decision-making |
Pharmacology |
2023-01-09 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 7 |
Section 1: Direct Patient Care |
Pharmacology |
2023-01-10 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 7 |
Section 2: Professionalism |
Pharmacology |
2023-01-10 |
Lane.Wendy |
9 |
0 |
edit |
|
Module 7 |
Section 3:Telephone, fax and e-mail communication |
Pharmacology |
2023-01-10 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 7 |
Section 4: Communication skills |
Pharmacology |
2023-01-10 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 7 |
Section 5: Communication challenges |
Pharmacology |
2023-01-10 |
Lane.Wendy |
8 |
0 |
edit |
|
Module 7 |
Section 6: Communication with specific populations |
Pharmacology |
2023-01-10 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 8 |
Section 1: Privacy rules: Effects on pharmacy operations |
Pharmacology |
2024-05-07 |
Lane.Wendy |
10 |
1 |
edit |
|
Module 8 |
Section 2: Privacy rules: Effects on pharmacy communications |
Pharmacology |
2024-05-07 |
Lane.Wendy |
9 |
1 |
edit |
|
Module 8 |
Section 3: Patient rights |
Pharmacology |
2024-05-07 |
Lane.Wendy |
7 |
1 |
edit |
|
Module 8 |
Section 4: Employer and employee responsibilities under HIPAA |
Pharmacology |
2024-05-07 |
Lane.Wendy |
10 |
1 |
edit |
|
Module 9 |
Section 1:Types of third-party programs |
Pharmacology |
2023-01-10 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 9 |
Section 2: Prescription reimbursement |
Pharmacology |
2023-01-10 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 9 |
Section 3: Dispensing third-party prescriptions and submitting claims |
Pharmacology |
2023-01-10 |
Lane.Wendy |
9 |
0 |
edit |
|
Module 9 |
Section 4: Third-party cost controls |
Pharmacology |
2023-01-10 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 9 |
Section 5:Claims reconciliation and ensuring payment |
Pharmacology |
2023-01-10 |
Lane.Wendy |
7 |
0 |
edit |
|
Abbreviations |
Chapters 1-11 |
Pharmacology |
2023-04-19 |
Lane.Wendy |
133 |
0 |
edit |
|
Module 10 |
Section 2: Purchasing: Ordering procedures |
Pharmacology |
2023-01-17 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 10 |
Section 3: Receiving and stocking medications |
Pharmacology |
2023-01-17 |
Lane.Wendy |
9 |
0 |
edit |
|
Module 10 |
Section 4: Returning merchandise |
Pharmacology |
2023-01-17 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 10 |
Section 5: Maintaining pharmacy department efficiency |
Pharmacology |
2023-01-17 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 11 |
Section 1: Dissection of medical terms |
Pharmacology |
2023-09-12 |
Lane.Wendy |
10 |
1 |
edit |
|
Module 11 |
Section 2: Patient medical charts and patient profiles |
Pharmacology |
2023-01-24 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 11 |
Section 3: General abbreviations found in a patient charts |
Pharmacology |
2023-01-24 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 11 |
Section 4: Abbreviations for diseases and conditions |
Pharmacology |
2023-01-24 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 11 |
Section 5: Abbreviations for laboratory and diagnostic tests |
Pharmacology |
2023-01-24 |
Lane.Wendy |
11 |
0 |
edit |
|
Module 11 |
Section 6: Medication terminology |
Pharmacology |
2023-01-24 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 12 |
Section 1:The skeletal system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 12 |
Section 2: The muscular system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 12 |
Section 3: The cardiovascular system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 12 |
Section 4: The hematologic system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
MJCC EHR |
Electronic Health Record |
Medical |
2024-04-05 |
Lane.Wendy |
145 |
3 |
edit |
|
Module 12 |
Section 6: The lymphatic and immune systems |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 12 |
Section 7: The digestive system |
Unfinished |
2024-01-31 |
Lane.Wendy |
9 |
0 |
edit |
|
Module 12 |
Section 8: The urinary system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
11 |
0 |
edit |
|
Module 12 |
Section 9: The nervous system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 12 |
Section 10: The integumentary system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 12 |
Section 11: The Endocrine system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 12 |
Section 12: The Reproductive system |
Pharmacology |
2024-01-31 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 1: Pharmacodynamics |
Pharmacology |
2023-05-01 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 2: Phamacokinetics |
Unfinished |
2023-05-01 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Drug interactions: General concepts |
Pharmacology |
2023-05-01 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 4: Drug-to-drug interactions |
Unfinished |
2023-05-01 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 5: Examples of drug-to-drug interactions |
Pharmacology |
2023-05-03 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 6: Drug-food interactions |
Pharmacology |
2023-05-04 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 7: Drug-disease interactions |
Pharmacology |
2023-05-04 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 8: Toxicology, overdoses, and antidotes |
Pharmacology |
2023-05-05 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 9: Medication actions on the nervous system |
Pharmacology |
2023-05-12 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 10: Autonomic nervous system receptors |
Pharmacology |
2023-05-12 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 13 |
Section 11: Medications affecting the autonomic nervous system |
Pharmacology |
2023-05-12 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 14 |
Section 1:Terms associated with disease states |
Pharmacology |
2023-05-26 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 14 |
Section 2: Hypertension |
Pharmacology |
2023-05-26 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 14 |
Section 3: Hyperlipidemia |
Pharmacology |
2023-05-26 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 14 |
Section 4: Diabetes mellitus |
Pharmacology |
2023-05-26 |
Lane.Wendy |
10 |
0 |
edit |
|
Module 14 |
Section 5: Influenza |
Pharmacology |
2023-05-26 |
Lane.Wendy |
11 |
0 |
edit |
|
Module 14 |
Section 6: Pneumonia |
Pharmacology |
2023-05-26 |
Lane.Wendy |
10 |
0 |
edit |
|
Chapter 1 |
Brand/generics, abbreviations, conversion factors |
Pharmacology |
2023-10-13 |
Lane.Wendy |
24 |
0 |
edit |
|
Chapter 1-2 |
Brand/generics conversions, abbreviations |
Pharmacology |
2023-10-13 |
Lane.Wendy |
50 |
0 |
edit |
|
Chapters 1-3 |
Brand/generic |
Pharmacology |
2023-11-09 |
Lane.Wendy |
26 |
0 |
edit |
|
Chapters 1-3 |
Abbreviations |
Pharmacology |
2023-11-09 |
Lane.Wendy |
35 |
0 |
edit |
|
Chapters 1-3 |
Conversions |
Unfinished |
2023-11-09 |
Lane.Wendy |
18 |
0 |
edit |
|
Chapters 1-4 |
Brand/generics |
Pharmacology |
2023-11-09 |
Lane.Wendy |
32 |
0 |
edit |
|
Chapters 1-4 |
Conversions |
Pharmacology |
2023-11-09 |
Lane.Wendy |
18 |
0 |
edit |
|
Chapter 1-5 |
Brand/generics |
Pharmacology |
2024-05-07 |
Lane.Wendy |
55 |
1 |
edit |
|
Chapters 1-5 |
Abbreviaitons |
Pharmacology |
2024-05-07 |
Lane.Wendy |
61 |
1 |
edit |
|